|Bid||10.11 x 0|
|Ask||10.11 x 0|
|Day's Range||10.06 - 10.81|
|52 Week Range||4.55 - 24.75|
|PE Ratio (TTM)||48.28|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||19.08|
Broken Coast Cannabis Nearly Doubles Production Capacity with Health Canada Approval of Phase III Expansion
Scythian Biosciences Corp. (the "Company" or “Scythian”) (SCYB.V) (9SB.F) (OTC – Nasdaq Intl:SCCYF) is pleased to announce that Argentina-based ABP S.A. (“ABP”), a pharmaceutical import and distribution company that Scythian is in the process of acquiring, has received its first purchase order (the “Order”) of CBD oil, which is to be fulfilled under the supply agreement with Aphria Inc. (APH.TO) (“Aphria”), a prominent Canadian producer of medical cannabis. The Order is for Aphria’s renowned CBD oil strain, Rideau.
Canada's main stock index rose to a 12-day high on Tuesday as technology and energy shares climbed and domestic data showed a stronger-than-expected gain for manufacturing sales. * The Toronto Stock Exchange's ...
Aphria Launches Solei, its First Adult-Use Brand, Designed for the Modern Cannabis Consumer
Canada's main stock index rose on Monday, led by industrial and financial shares, as fears waned of an escalating conflict in Syria following the weekend's U.S.-led air strikes. * The Toronto Stock Exchange's ...
Canada's benchmark index was slightly higher on Monday, helped by industrial shares and waning fears of an escalating conflict in Syria following the weekend's U.S.-led air strikes. * At 9:53 a.m. ET , ...
Canada's main stock index was little changed on Friday as gains for the shares of mining and energy companies were offset by declines in financial stocks. * The Toronto Stock Exchange's S&P/TSX composite index closed up 4.7 points, or 0.03 percent, at 15,273.97. * Gold futures rose 0.5 percent to $1,344.6 an ounce.
Hydropothecary Corp, Canopy Growth and Aphria Inc are among six companies that have signed agreements with Quebec's liquor board to supply the province with marijuana when Canada legalizes its recreational use this year, the companies said in separate statements on Wednesday. MedReleaf Corp, Aurora Cannabis and private equity firm Privateer Holdings-backed Tilray Canada are the other companies to sign the deal to supply the province's cannabis board, which will be created as a subsidiary of the liquor board to oversee marijuana sales.
Aphria finalizes three-year supply agreement with the SAQ to provide up to 12,000 kg of cannabis annually to Quebec market
NEW YORK, NY / ACCESSWIRE / April 9, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
Canadian cannabis companies are making headlines for sky-high valuations, high-profile acquisitions, and international expansion plays. Some of this hype is justified, as Canada seeks to become the world's largest country to legalize cannabis, but are these bullish valuations built on shaky ground?
A cold rain beat down recently on the boarded-up cinder-block homes and empty factories of Smiths Falls, Ontario, melting the last snows in this industrial town about an hour south of Ottawa. Inside a shuttered chocolate factory, it is artificial summer for the marijuana crop of the largest cannabis company in the world, Canopy Growth. In brightly lit, high-tech “grow rooms,” Canopy is preparing for the expected legalization of recreational cannabis this year in Canada—the first industrialized nation to do so at the federal level.
LEAMINGTON, ON, March 27, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) is pleased to provide the following updates to the Company's worldwide operations and activities. Nuuvera Inc. will be renamed Aphria International Inc. ("Aphria International") and remain a wholly-owned subsidiary of Aphria.
Canada's main stock index climbed on Monday from five-week lows, led by gains in financial stocks, as reports of talks between the United States and China eased trade war worries. China scrambled to avert ...
LEAMINGTON, ON, March 21, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced that it has signed an exclusive supply agreement with an Argentinan based pharmaceutical import and distribution company, which is licensed to import, sell and distribute medical products and derivatives in Argentina. The importer is currently securing an import license for cannabis in Argentina. "We are excited to enter the Argentinian market through this initial supply agreement," said Vic Neufeld, CEO of Aphria. "We see tremendous potential for medical cannabis in several emerging markets in South America, including Argentina.
Aphria signs exclusive agreement with Argentina-based importer to supply medical cannabis in Argentina
Aphria receives third-party independent GMP certification of Leamington growing and processing facilities
LEAMINGTON, ON, March 16, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today announced it has received third-party independent GMP certification of its Leamington, Ontario growing and processing facilities. Granted by internationally-renowned firm SGS, the certification is for the current Good Manufacturing Practice ("cGMP") standards of CFR 21 parts 210/211 established by the United States Food and Drug Administration ("USFDA") for Active Pharmaceutical Ingredients and Finished Pharmaceuticals.
Aphria's Australian-based partner Althea receives Medical Cannabis License for cultivation